Cartesian Therapeutics

RNACNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$260.026 M

$8.85 +1.03%

Close of 7 Aug 2026

Revenue

$2.80M

#3399 by revenue

Earnings

-$130.3M

Loss-making

Shares outstanding

30,255,352

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#248Camp4 TherapeuticsCAMP$265.9M
#249ProQR TherapeuticsPRQR$264.6M
#250Cartesian TherapeuticsRNAC$260.0M
#251MacrogenicsMGNX$256.8M
#252Whitehawk TherapeuticsWHWK$256.0M

Where these numbers come from

Share counts and financials for Cartesian Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.